MS MS - Takara Bio Ex Director
| TF2 Stock | EUR 5.40 1.14 26.76% |
Insider
MS MS is Ex Director of Takara Bio
| Address | 7-4-38 Nojihigashi, Kusatsu, Japan, 525-0058 |
| Phone | 81 77 565 6920 |
| Web | https://www.takara-bio.com |
Takara Bio Management Efficiency
At this time, Takara Bio's Intangible Assets are most likely to increase significantly in the upcoming years. The Takara Bio's current Non Currrent Assets Other is estimated to increase to about 1.8 B, while Total Assets are projected to decrease to roughly 97.1 B. Takara Bio's management efficiency ratios could be used to measure how well Takara Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Hag Kim | POSCO Holdings | 60 | |
| Takashige Shibato | Fukuoka Financial Group | 65 | |
| Takujiro Mori | Fukuoka Financial Group | 61 | |
| Hideo Yamada | Fukuoka Financial Group | 64 | |
| Satoshi Kobayashi | Fukuoka Financial Group | N/A | |
| Masanori Kuwata | Toyota Motor | N/A | |
| Yan Xiong | Industrial and Commercial | 59 | |
| Masayuki Aoyagi | Fukuoka Financial Group | 63 | |
| Liqun Cao | Industrial and Commercial | 48 | |
| Kazunori Tanaka | Fukuoka Financial Group | 58 | |
| Toshiaki Taguchi | Toyota Motor | 72 | |
| JhiYong Kim | POSCO Holdings | 61 | |
| JungBae Lee | Samsung Electronics Co | 56 | |
| Akio Toyoda | Toyota Motor | 67 | |
| HyeWoong Lee | LG Electronics | 62 | |
| SangBong Lee | LG Electronics | 69 | |
| Wenwu Zhang | Industrial and Commercial | 50 | |
| Bresson Xu | Industrial and Commercial | N/A | |
| Jaeseung Lee | Samsung Electronics Co | 63 | |
| Inhwa Chang | POSCO Holdings | 71 | |
| Mitsuo Yamanaka | Fukuoka Financial Group | N/A | |
Management Performance
| Return On Equity | -0.068 | ||||
| Return On Asset | -0.0053 |
Takara Bio Leadership Team
Elected by the shareholders, the Takara Bio's board of directors comprises two types of representatives: Takara Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Takara. The board's role is to monitor Takara Bio's management team and ensure that shareholders' interests are well served. Takara Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Takara Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Katsuhiko Kusakabe, Managing Officer | ||
| Andrew Farmer, Head Development | ||
| Junichi Mineno, Executive VP | ||
| Ikuei Nukaya, Managing Headquarters | ||
| Koichi Nakao, Pres CEO | ||
| MS MS, Ex Director | ||
| Mutsumi Sano, Sr Officer | ||
| Yoh Hamaoka, Executive VP | ||
| Tsuyoshi Miyamura, CEO President | ||
| Akira Kodera, Managing Division | ||
| Kyoko Nakajima, Senior Division | ||
| Masanari Kitagawa, Ex Officer | ||
| Noritaka Nishiwaki, Deputy Officer |
Takara Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Takara Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.068 | ||||
| Return On Asset | -0.0053 | ||||
| Profit Margin | (0.16) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 470.83 M | ||||
| Shares Outstanding | 120.42 M | ||||
| Shares Owned By Insiders | 61.73 % | ||||
| Shares Owned By Institutions | 7.23 % | ||||
| Price To Earning | 52.31 X | ||||
| Price To Book | 1.15 X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Takara Stock
Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.